Nemaura Medical Inc.
NMRD · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $22 | $102 | $170 | $122 |
| - Cash | $10 | $18 | $32 | $0 |
| + Debt | $20 | $19 | $25 | $0 |
| Enterprise Value | $32 | $104 | $163 | $122 |
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -84.7% | – | – | – |
| Gross Profit | -$1 | $0 | -$0 | $0 |
| % Margin | -1,916.3% | 31.7% | – | – |
| EBITDA | -$7 | -$7 | -$4 | -$5 |
| % Margin | -9,458.3% | -1,456.7% | – | – |
| Net Income | -$14 | -$14 | -$6 | -$4 |
| % Margin | -18,358% | -2,755.8% | – | – |
| EPS Diluted | -0.57 | -0.59 | -0.28 | -0.2 |
| % Growth | 3.4% | -110.7% | -40% | – |
| Operating Cash Flow | -$8 | -$7 | -$6 | -$3 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$9 | -$7 | -$7 | -$4 |